Assertio (ASRT) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ASRT Stock Forecast


Assertio stock forecast is as follows: an average price target of $2.88 (represents a 171.70% upside from ASRT’s last price of $1.06) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

ASRT Price Target


The average price target for Assertio (ASRT) is $2.88 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $2.75. This represents a potential 171.70% upside from ASRT's last price of $1.06.

ASRT Analyst Ratings


Buy

According to 2 Wall Street analysts, Assertio's rating consensus is 'Buy'. The analyst rating breakdown for ASRT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Assertio Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 26, 2024Naz RahmanMaxim Group$3.00$1.47104.08%183.02%
May 28, 2024Scott HenryIndustrial Alliance Securities$2.75$1.00175.00%159.43%
Row per page
Go to

The latest Assertio stock forecast, released on Jul 26, 2024 by Naz Rahman from Maxim Group, set a price target of $3.00, which represents a 104.08% increase from the stock price at the time of the forecast ($1.47), and a 183.02% increase from ASRT last price ($1.06).

Assertio Price Target by Period


1M3M12M
# Anlaysts--2
Avg Price Target--$2.88
Last Closing Price$1.06$1.06$1.06
Upside/Downside-100.00%-100.00%171.70%

In the current month, the average price target of Assertio stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Assertio's last price of $1.06. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Jul 03, 2024H.C. Wainwright-BuyInitialise
May 28, 2024Alliance Global Partners-BuyInitialise
Row per page
Go to

Assertio's last stock rating was published by H.C. Wainwright on Jul 03, 2024. The company Initialise its ASRT rating from "null" to "Buy".

Assertio Financial Forecast


Assertio Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$35.63M$40.99M$42.47M$50.35M$34.21M$35.13M$36.54M$33.33M$25.47M$25.37M$26.84M$30.18M$34.56M$20.62M$20.92M$59.23M$55.15M
Avg Forecast$29.00M$29.20M$29.41M$29.62M$34.12M$32.88M$31.80M$30.99M$29.30M$28.87M$30.08M$29.30M$33.60M$50.17M$39.83M$37.64M$47.33M$31.36M$31.78M$32.66M$30.38M$21.64M$19.98M$23.98M$27.30M$32.35M$25.17M$10.95M$25.01M$50.57M
High Forecast$29.00M$29.20M$29.41M$29.62M$34.12M$32.88M$31.80M$30.99M$29.30M$29.22M$30.08M$29.30M$33.60M$50.30M$39.83M$37.64M$47.33M$31.36M$31.78M$32.66M$30.38M$21.64M$19.98M$23.98M$27.30M$32.35M$25.17M$10.95M$25.01M$50.57M
Low Forecast$29.00M$29.20M$29.41M$29.62M$34.12M$32.88M$31.80M$30.99M$29.30M$28.51M$30.08M$29.30M$33.60M$50.05M$39.83M$37.64M$47.33M$31.36M$31.78M$32.66M$30.38M$21.64M$19.98M$23.98M$27.30M$32.35M$25.17M$10.95M$25.01M$50.57M
# Analysts111111111311111111111111999955
Surprise %-------------0.71%1.03%1.13%1.06%1.09%1.11%1.12%1.10%1.18%1.27%1.12%1.11%1.07%0.82%1.91%2.37%1.09%

Assertio's average Quarter revenue forecast for Dec 23 based on 1 analysts is $33.60M, with a low forecast of $33.60M, and a high forecast of $33.60M. ASRT's average Quarter revenue forecast represents a -5.69% decrease compared to the company's last Quarter revenue of $35.63M (Sep 23).

Assertio EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311111111111111999955
EBITDA-------------$-228.27M$19.80M$21.10M$29.90M$18.38M$19.96M$22.45M$14.86M$13.69M$-4.39M$14.59M$-25.85M$-273.00K$-37.12M$60.02M$-158.70M$41.21M
Avg Forecast$8.76M$8.83M$8.89M$8.95M$10.31M$9.94M$9.61M$9.37M$8.85M$8.72M$9.09M$26.23M$10.15M$15.16M$12.04M$20.73M$5.32M$9.48M$9.60M$16.39M$9.18M$6.54M$6.04M$16.05M$8.25M$9.78M$7.61M$3.31M$7.56M$15.28M
High Forecast$8.76M$8.83M$8.89M$8.95M$10.31M$9.94M$9.61M$9.37M$8.85M$8.83M$9.09M$31.47M$10.15M$15.20M$12.04M$24.88M$6.39M$9.48M$9.60M$19.67M$9.18M$6.54M$6.04M$19.26M$8.25M$9.78M$7.61M$3.31M$7.56M$15.28M
Low Forecast$8.76M$8.83M$8.89M$8.95M$10.31M$9.94M$9.61M$9.37M$8.85M$8.62M$9.09M$20.98M$10.15M$15.12M$12.04M$16.59M$4.26M$9.48M$9.60M$13.11M$9.18M$6.54M$6.04M$12.84M$8.25M$9.78M$7.61M$3.31M$7.56M$15.28M
Surprise %--------------15.06%1.64%1.02%5.62%1.94%2.08%1.37%1.62%2.09%-0.73%0.91%-3.13%-0.03%-4.88%18.14%-21.00%2.70%

1 analysts predict ASRT's average Quarter EBITDA for Sep 23 to be $15.16M, with a high of $15.20M and a low of $15.12M. This is -23.43% lower than Assertio's previous annual EBITDA (Jun 23) of $19.80M.

Assertio Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311111111111111999955
Net Income-------------$-279.54M$8.47M$-3.48M$88.55M$4.17M$7.83M$9.06M$4.61M$3.74M$-14.17M$4.54M$-24.35M$-10.52M$-34.50M$41.23M$-192.63M$3.33M
Avg Forecast$6.67M$4.76M$3.81M$3.81M$952.40K$952.40K$-1.59M$-2.22M$-4.38M$-4.19M$-3.05M$11.43M$-1.90M$9.05M$17.68M$9.03M$-17.02M$6.70M$9.52M$7.14M$7.62M$11.43M$11.43M$5.00M$-13.33M$-11.43M$-32.38M$120.60M$53.33M$92.70M
High Forecast$6.67M$4.76M$3.81M$3.81M$952.40K$952.40K$-1.59M$-2.22M$-4.38M$-3.14M$-3.05M$13.71M$-1.90M$9.05M$17.68M$10.84M$-13.62M$6.70M$9.52M$8.57M$7.62M$11.43M$11.43M$6.00M$-13.33M$-11.43M$-32.38M$144.72M$53.33M$92.70M
Low Forecast$6.67M$4.76M$3.81M$3.81M$952.40K$952.40K$-1.59M$-2.22M$-4.38M$-5.24M$-3.05M$9.14M$-1.90M$9.05M$17.68M$7.23M$-20.43M$6.70M$9.52M$5.71M$7.62M$11.43M$11.43M$4.00M$-13.33M$-11.43M$-32.38M$96.48M$53.33M$92.70M
Surprise %--------------30.90%0.48%-0.39%-5.20%0.62%0.82%1.27%0.60%0.33%-1.24%0.91%1.83%0.92%1.07%0.34%-3.61%0.04%

Assertio's average Quarter net income forecast for Sep 23 is $9.05M, with a range of $9.05M to $9.05M. ASRT's average Quarter net income forecast represents a 6.82% increase compared to the company's last Quarter net income of $8.47M (Jun 23).

Assertio SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311111111111111999955
SG&A-------------$21.00M$16.77M$16.90M$13.71M$11.90M$10.54M$10.64M$13.28M$9.31M$26.23M$7.73M$23.13M$25.75M$28.13M$27.31M$22.95M$36.12M
Avg Forecast$15.77M$15.88M$15.99M$16.11M$18.55M$17.88M$17.29M$16.85M$15.93M$15.70M$16.36M$13.41M$18.27M$27.28M$21.66M$10.60M$24.85M$17.05M$17.28M$8.38M$16.52M$11.77M$10.87M$8.50M$14.84M$17.59M$13.69M$5.95M$13.60M$27.50M
High Forecast$15.77M$15.88M$15.99M$16.11M$18.55M$17.88M$17.29M$16.85M$15.93M$15.89M$16.36M$16.09M$18.27M$27.35M$21.66M$12.72M$29.82M$17.05M$17.28M$10.06M$16.52M$11.77M$10.87M$10.20M$14.84M$17.59M$13.69M$5.95M$13.60M$27.50M
Low Forecast$15.77M$15.88M$15.99M$16.11M$18.55M$17.88M$17.29M$16.85M$15.93M$15.51M$16.36M$10.73M$18.27M$27.21M$21.66M$8.48M$19.88M$17.05M$17.28M$6.71M$16.52M$11.77M$10.87M$6.80M$14.84M$17.59M$13.69M$5.95M$13.60M$27.50M
Surprise %-------------0.77%0.77%1.59%0.55%0.70%0.61%1.27%0.80%0.79%2.41%0.91%1.56%1.46%2.06%4.59%1.69%1.31%

Assertio's average Quarter SG&A projection for Dec 23 is $18.27M, based on 1 Wall Street analysts, with a range of $18.27M to $18.27M. The forecast indicates a -13.02% fall compared to ASRT last annual SG&A of $21.00M (Sep 23).

Assertio EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311111111111111999955
EPS-------------$-3.42$0.15$-0.07$1.83$0.09$0.17$0.20$0.10$0.08$-0.32$0.12$-0.80$-0.36$-1.40$2.32$-10.60$0.20
Avg Forecast$0.07$0.05$0.04$0.04$0.01$0.01$-0.02$-0.02$-0.05$-0.04$-0.03$-0.01$-0.02$0.10$0.19$0.18$0.57$0.07$0.10$0.08$0.08$0.12$0.12$0.08$-0.14$-0.12$-0.34$-0.32$0.56$0.97
High Forecast$0.07$0.05$0.04$0.04$0.01$0.01$-0.02$-0.02$-0.05$-0.03$-0.03$-0.01$-0.02$0.10$0.19$0.18$0.57$0.07$0.10$0.08$0.08$0.12$0.12$0.08$-0.14$-0.12$-0.34$-0.32$0.56$0.97
Low Forecast$0.07$0.05$0.04$0.04$0.01$0.01$-0.02$-0.02$-0.05$-0.06$-0.03$-0.01$-0.02$0.10$0.19$0.18$0.57$0.07$0.10$0.08$0.08$0.12$0.12$0.08$-0.14$-0.12$-0.34$-0.32$0.56$0.97
Surprise %--------------36.00%0.81%-0.38%3.20%1.28%1.70%2.50%1.25%0.67%-2.67%1.50%5.71%3.00%4.12%-7.25%-18.93%0.21%

According to 1 Wall Street analysts, Assertio's projected average Quarter EPS for Sep 23 is $0.10, with a low estimate of $0.10 and a high estimate of $0.10. This represents a -36.67% decrease compared to ASRT previous annual EPS of $0.15 (Jun 23).

Assertio Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ESPREsperion Therapeutics$2.00$16.00700.00%Buy
IRWDIronwood Pharmaceuticals$4.19$11.67178.52%Buy
ASRTAssertio$1.06$2.88171.70%Buy
PCRXPacira BioSciences$16.45$40.00143.16%Hold
EOLSEvolus$16.42$24.0046.16%Buy
ANIPANI Pharmaceuticals$56.01$79.0041.05%Buy
AMPHAmphastar Pharmaceuticals$50.59$66.0030.46%Buy
CTLTCatalent$58.69$76.4030.18%Hold
ALKSAlkermes$26.59$34.3829.30%Hold
COLLCollegium Pharmaceutical$32.72$41.5026.83%Buy
ALVOAlvotech$12.92$16.0023.84%Hold
NBIXNeurocrine Biosciences$120.53$147.7022.54%Buy
ITCIIntra-Cellular Therapies$86.17$94.509.67%Buy
LFCRLifecore Biomedical$5.99$6.508.51%Buy
DCPHDeciphera Pharmaceuticals$25.59$26.322.85%Hold
AMRXAmneal Pharmaceuticals$8.41$8.00-4.88%Buy
AGRXAgile Therapeutics$1.51$1.00-33.77%Buy

ASRT Forecast FAQ


Yes, according to 2 Wall Street analysts, Assertio (ASRT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of ASRT's total ratings.

Assertio (ASRT) average price target is $2.88 with a range of $2.75 to $3, implying a 171.70% from its last price of $1.06. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for ASRT stock, the company can go up by 171.70% (from the last price of $1.06 to the average price target of $2.88), up by 183.02% based on the highest stock price target, and up by 159.43% based on the lowest stock price target.

ASRT's average twelve months analyst stock price target of $2.88 supports the claim that Assertio can reach $2 in the near future.

Assertio's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $129.79M (high $129.79M, low $129.79M), average EBITDA is $39.22M (high $39.22M, low $39.22M), average net income is $-1.905M (high $-1.905M, low $-1.905M), average SG&A $70.58M (high $70.58M, low $70.58M), and average EPS is $-0.02 (high $-0.02, low $-0.02). ASRT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $117.24M (high $117.24M, low $117.24M), average EBITDA is $35.43M (high $35.43M, low $35.43M), average net income is $19.05M (high $19.05M, low $19.05M), average SG&A $63.75M (high $63.75M, low $63.75M), and average EPS is $0.2 (high $0.2, low $0.2).

Based on Assertio's last annual report (Dec 2022), the company's revenue was $156.23M, beating the average analysts forecast of $143.13M by 9.16%. Apple's EBITDA was $91.21M, beating the average prediction of $40.79M by 123.58%. The company's net income was $109.62M, beating the average estimation of $6.34M by 1629.07%. Apple's SG&A was $46.79M, missing the average forecast of $67.56M by -30.75%. Lastly, the company's EPS was $2.33, beating the average prediction of $0.822 by 183.34%. In terms of the last quarterly report (Sep 2023), Assertio's revenue was $35.63M, missing the average analysts' forecast of $50.17M by -28.99%. The company's EBITDA was $-228M, missing the average prediction of $15.16M by -1605.57%. Assertio's net income was $-280M, missing the average estimation of $9.05M by -3189.64%. The company's SG&A was $21M, missing the average forecast of $27.28M by -23.01%. Lastly, the company's EPS was $-3.42, missing the average prediction of $0.095 by -3700.00%